PDS Biotechnology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.

About PDSB

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. 

CEO
Frank K. Bedu-Addo
CEOFrank K. Bedu-Addo
Employees
24
Employees24
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2005
Founded2005
Employees
24
Employees24

PDSB Key Statistics

Market cap
65.36M
Market cap65.36M
Price-Earnings ratio
-1.68
Price-Earnings ratio-1.68
Dividend yield
Dividend yield
Average volume
1.09M
Average volume1.09M
High today
$1.59
High today$1.59
Low today
$1.42
Low today$1.42
Open price
$1.57
Open price$1.57
Volume
862.07K
Volume862.07K
52 Week high
$4.42
52 Week high$4.42
52 Week low
$0.8505
52 Week low$0.8505

People also own

Based on the portfolios of people who own PDSB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.